The AntibOZ International conferences were focussed on engineered antibodies and predicting the next wave of Protein-based Biopharmaceuticals, Medical Imaging and Clinical Diagnostics.  Past conferences were held in 2002, 2004 and 2007 on Heron Island (Great Barrier Reef, Australia).

Each conference hosted over 100 delegates including most major biopharmaceutical companies and International scientific leaders in antibody development. The impressive list of previous participants have included Abbott, Abgenix, Affitech, Alexion, Amgen, BD-Biosciences, CAT, CSL, Domantis, Dyax, EvoGenix, Genmab, ImClone, KaloBios, Medarex, Micromet, PanBio, Panorama, Peptech, Serenex, Viventia and Wyeth. International leaders in antibody development have included Greg Winter, Martin Glennie, Dennis Burton, Anna Wu, Greg Adams, Ian Tomlinson, John McCafferty, Marc De Souza, Carlos Barbas III, Bob Ladner, Larry Green, Geoff Davis, Andrew Bradbury, Paul Parren, Jan van de Winkel, Jim Marks, Melvyn Little, Alex Duncan, Patrick Baeuerle, Boris Labkovsky, Nitin Damle, Peter Bohlen and many others.

The next conference in this series, AntibOZ-4, will be held on Sept 30-Oct 3rd 2010 on Dunk Island, North Queensland.